Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Response to NYS on Proposed Changes to Onsite Work Requirements for Lab Directors
-
Sign-on Letter Opposing Cigna Policy on Use of Modifier -25
-
ACMG Comments to the CLIAC Regarding Remote Laboratory Work
-
ACMG Response to Senate HELP Committee RFI on Healthcare Workforce Shortages
-
Sign-on Letter Opposing Updated VALID Act & ACM Exemption
-
ACMG Comments on CMS Proposed Rule for Changes to CLIA Personnel Requirements
-
Joint statement from Medical Associations Opposing Legislative Interference in Healthcare
-
Sign-on Letter to Congressional Leadership Concerning the VALID Act
-
ACMG Comments on FDA Draft Guidance for Products Incorporating Genome Editing
-
Group Sign-on Letter Concerning the VALID Act of 2022 Discussion Draft